The drug clesrovimab also helped reduce RSV associated hospitalizations by 84.2% compared to placebo, Merck said.
A large new study says the RSV vaccine is 80% effective at preventing hospitalization in older adults due to complications from the illness, and works just as well at protecting them from death or ...
A global real-world study of the vaccine for respiratory syncytial virus (RSV) finds it offers folks aged 60 and over 80% ...